The prospective randomized study on telaprevir at 1500 or 2250 mg with pegylated interferon plus ribavirin in Japanese patients with HCV genotype 1-Reference-Cited by-同舟云学术

The prospective randomized study on telaprevir at 1500 or 2250 mg with pegylated interferon plus ribavirin in Japanese patients with HCV genotype 1

Published:2014-05-08 Issue:3 Volume:50 Page:313-322
ISSN:0944-1174
Container-title:Journal of Gastroenterology
language:en
Short-container-title:J Gastroenterol

Author:

Oze Tsugiko,Hiramatsu Naoki,Yakushijin Takayuki,Yamada Ryoko,Harada Naoki,Morishita Naoki,Yamada Akira,Oshita Masahide,Kaneko Akira,Suzuki Kunio,Inui Yoshiaki,Tamura Shinji,Yoshihara Harumasa,Imai Yasuharu,Miyagi Takuya,Yoshida Yuichi,Tatsumi Tomohide,Kasahara Akinori,Hayashi Norio,Takehara Tetsuo

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

http://link.springer.com/content/pdf/10.1007/s00535-014-0965-8.pdf

Reference19 articles.

1. Ghany MG, Nelson DR, Strader DB, et al. An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology. 2011;54:1433–44.

2. McHutchison JG, Everson GT, Gordon SC, et al. Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection. N Engl J Med. 2009;360:1827–38.

3. Hezode C, Forestier N, Dusheiko G, et al. Telaprevir and peginterferon with or without ribavirin for chronic HCV infection. N Engl J Med. 2009;360:1839–50.

4. McHutchison JG, Manns MP, Muir AJ, et al. Telaprevir for previously treated chronic HCV infection. N Engl J Med. 2010;362:1292–303.

5. Jacobson IM, McHutchison JG, Dusheiko G, et al. Telaprevir for previously untreated chronic hepatitis C virus infection. N Engl J Med. 2011;364:2405–16.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Safety Profile of Telaprevir-Based Triple Therapy in Clinical Practice: A Retrospective Cohort Study;Biological & Pharmaceutical Bulletin;2017

2. Features of the Second Wave of the First Generation Protease Inhibitors: Effect and Tolerance;Hepatitis C Virus Treatment;2016-11-02

3. Efficacy and safety of telaprevir with pegylated interferon α-2a and ribavirin in Japanese patients;Hepatology Research;2016-06-04

4. Effectiveness of triple therapy with simeprevir for chronic hepatitis C genotype 1b patients with prior telaprevir failure;Journal of Viral Hepatitis;2015-06-15

5. The real impact of telaprevir dosage on the antiviral and side effects of telaprevir, pegylated interferon and ribavirin therapy for chronic hepatitis C patients with HCV genotype 1;Journal of Viral Hepatitis;2014-07-31